Dr. Everardo Cobos, MD

Dr. Cobos practices at McAllen Surgery Center (N Jackson Rd) in Mcallen, Texas.

Dr. Cobos' NPI, 1194713354, was assigned on October 12, 2005. Dr. Cobos graduated from Joe R. & Teresa Lozano Long School of Medicine in 1981. Dr. Cobos holds Texas license H3808.

Dr. Cobos' primary practice is McAllen Surgery Center (N Jackson Rd), at 4211 North Jackson Road, Mcallen, TX 78504. The practice phone is (999) 999-9999.

Dr. Cobos' primary practice is McAllen Surgery Center (N Jackson Rd) in Mcallen, Texas. The medical group on file is UT Health RGV. Dmand AI also links Dr. Cobos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cobos practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cobos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cobos is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Cobos' licenses on file in 2 states: Texas and California.

Dmand AI lists breast cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Cobos treats.

CMS data shows 145 Medicare services from Dr. Cobos across 5 procedure codes in 2022, for 23 Medicare patients. Medicare paid $8,934 for them.

CMS counts 23 Medicare patients who saw Dr. Cobos in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cobos' median patient age at 65, with 67% women.

In 2024, Dr. Cobos wrote 40 Medicare Part D claims for 11 patients. 90% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $143,034 in total drug cost. In 2022, CMS named 78 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cobos for performance year 2024, reported as part of a group. Dr. Cobos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 122 papers to Dr. Cobos, published from 2005 to 2025. 2014 was the busiest year, with 5. The most frequent topics are Antigens, Neoplasm, Immunotherapy and Cell Line, Tumor. Dr. Cobos has published most often in J Investig Med High Impact Case Rep. Dr. Cobos' most frequent co-authors are Yi-Kong Keung, MD, Jose A. Figueroa, MD and Greti Ileana Petersen.

CMS Open Payments shows 202 general payments to Dr. Cobos from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Millennium Pharmaceuticals, Inc. paid the most, $29,011.

Dr. Cobos graduated from Joe R. & Teresa Lozano Long School of Medicine in 1981.

Dr. Cobos is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.